Atlas Trials

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Clinical trial NCT01040026 · COMPLETED

Trial details

NCT number
NCT01040026
Sponsor
University Hospital, Basel, Switzerland
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-10-01
Primary completion
2016-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.